{
    "organizations": [],
    "uuid": "bb3595e6a2cc9354e8e6c8cb1cad53d0419014ca",
    "author": "",
    "url": "https://www.reuters.com/article/brief-roche-expands-indication-for-cobas/brief-roche-expands-indication-for-cobas-egfr-mutation-test-v2-as-companion-diagnostic-with-tagrisso-idUSFWN1RV10E",
    "ord_in_thread": 0,
    "title": "BRIEF-Roche Expands Indication For Cobas EGFR Mutation Test V2 As Companion Diagnostic With Tagrisso",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Roche Holding AG:\n* ROCHE EXPANDS INDICATION FOR COBAS® EGFR MUTATION TEST V2 AS A COMPANION DIAGNOSTIC WITH TAGRISSO®\n* ROCHE HOLDING- NEW INDICATION AS COMPANION DIAGNOSTIC WITH ASTRAZENECA’S TAGRISSO IN FIRST LINE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER\n* ROCHE -RECEIVED APPROVAL FROM FDA OF ITS PMA SUPPLEMENT FOR COBAS EGFR MUTATION TEST V2 TO BE USED AS COMPANION DIAGNOSTIC TEST WITH TAGRISSO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T02:22:00.000+03:00",
    "crawled": "2018-04-19T02:41:07.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "roche",
        "holding",
        "ag",
        "roche",
        "expands",
        "indication",
        "egfr",
        "mutation",
        "test",
        "v2",
        "companion",
        "diagnostic",
        "roche",
        "new",
        "indication",
        "companion",
        "diagnostic",
        "astrazeneca",
        "tagrisso",
        "first",
        "line",
        "treatment",
        "patient",
        "cell",
        "lung",
        "cancer",
        "roche",
        "approval",
        "fda",
        "pma",
        "supplement",
        "cobas",
        "egfr",
        "mutation",
        "test",
        "v2",
        "used",
        "companion",
        "diagnostic",
        "test",
        "tagrisso",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}